LAW_OF_ID Profile Banner
Nancy Law Profile
Nancy Law

@LAW_OF_ID

Followers
60
Following
40
Media
1
Statuses
117

Transplant/Onc ID Provider. ASP Champion. Medical Educator. Physician Wellness Advocate.

San Diego, CA
Joined April 2023
Don't wanna be here? Send us removal request.
@IDSAInfo
IDSA
5 months
The IDSA MedEd Community of Practice's Clinician Educator Coaching Program returns at #IDWeek2025! Graduating ID fellows & early-career faculty can get 1:1 coaching, while experienced faculty can volunteer to coach. Sign up by Aug. 15: https://t.co/71LaGRlUET
0
2
1
@CIDJournal
Clinical Infectious Diseases
5 months
The Impact of Synergistic Therapy Between Colistin and Meropenem on Outcomes of Patients With Pneumonia or Bloodstream Infection Due to Carbapenem-Resistant Gram-Negative Pathogens ✅ Just Accepted 🔗 https://t.co/zeUNZQ0quq
1
22
47
@jschaenman
Joanna Schaenman MD PhD
5 months
Transplant ID Career Development/Fellowship application is open at #UCLA! #TxID #ID #MedEd #IDFellow ! This is a 1-yr position- pls reach out with questions 🔬🦠💊@IDSAInfo @AST_IDCOP @TxID_Fellows
Tweet card summary image
recruit.apo.ucla.edu
University of California, Los Angeles is hiring. Apply now!
0
8
16
@JennyYangMD
Jenny Yang
5 months
Our review on distinguishing #CTEPH from in situ thrombosis is out in the new Right Heart Journal. Similarities exist but there are key imaging findings to differentiate between these which is critical as management is vastly different! @ucsdpccm @ATS_PC https://t.co/wqeGNdKUc1
0
4
8
@IDSAInfo
IDSA
5 months
ICYMI, IDSA released the first guidelines for the management and treatment of complicated urinary tract infections (cUTIs). The new guidelines simplify the prior definitions of uncomplicated UTIs and cUTIs, & address treatment for cUTIs. View guidelines: https://t.co/jauYIl0Zyv
1
93
218
@TransplantIDNet
transplantid.net
5 months
.@ASTCT has #ID #HSCT #CAR-T guidelines in @ASTCT_Journal https://t.co/BOMS6dj5fu "GUIDELINES"▶️ "ASTCT Guidelines"📁 #️⃣ 🔟 : Management of parainfluenza and hMPV after HSCT and CAR-T Thanks @AneelaMajeed5 @ClevelandClinic https://t.co/E8HEdYmu2a
0
10
20
@KottonNelson
Camille Nelson Kotton
6 months
Excited to have the 4th international CMV consensus guidelines officially published!!
@TransplantJrnl
Transplantation
6 months
July 2025 issue of @TransplantJrnl ! This issue highlights: ◼Consensus Guidelines on CMV Management ◼Organ Transplantation in the UAE ◼Sequential NRP and Normothermic Perfusion in Liver Transplantation ◼Predicting Long-Term Over-immunosuppression https://t.co/55buCjUaS4
0
15
44
@IDSAInfo
IDSA
7 months
Bloodstream infections (BSI) caused by carbapenem-resistant gram-negative bacilli (CR-GNB) are difficult-to-treat infections associated with high mortality. In @CIDJournal, Juan Pablo Balbuena and colleagues conducted the EMBARC-AR study in Argentina.
Tweet card summary image
academic.oup.com
This large prospective multicenter study in Argentina underscores the high mortality in patients with bloodstream infections due to carbapenem-resistant gr
2
28
61
@TransplantIDNet
transplantid.net
7 months
BAL Aspergillus PCR study in @TheTxIDJournal for identifying IPA in SOT - ⬇️ sensitivity ~ 67 % - ⬆️ specificity 98% (95% CI 93%–99%) in identifying IPA in SOT recipients. Added by @AneelaMajeed5 to "Fungal Diagnostics"📁 https://t.co/gK4r5XO7jg
0
15
42
@PaulSaxMD
Paul Sax
8 months
TB rule outs, Abx allergies, CMV, MSSA (of course), and more. Studies sent to an awesome ID fellow during 2 weeks of service — organized for subconscious absorption. 🧠 Link-o-Rama: Osmosis Edition
Tweet card summary image
blogs.nejm.org
First-year ID fellows this time of year bring a lot to inpatient consult rotations. Years of high-volume inpatient care have sharpened their clinical instincts, and at this point they have an...
1
34
93
@TransplantIDNet
transplantid.net
9 months
Considering building a #TxID training program? You can find a recipe in this @TheTxIDjournal review by @CourtHarrisMD @rebecca_kumar Ghady Haidar @RicardoLaHozMD @GorslineChelsea Added by @MariAleMendozaD to TRANSPLANT ID TRAINING▶️ Training program📂 https://t.co/NvjB9bNnAX
0
9
32
@ttsorg
TTS
8 months
🌟Save the date - BKV webinar🌟 Webinar 👉 BKV Infection in Kidney Transplant Recipients Focusing on LMIC 🗓️Thursday, May 8 at 10 am (ET) 📣Shyam Bansal, Soumita Bagchi, Laurie Bertels, Helio Tedesco Silva, Edwin Fernando, Umapati Hegde, @KottonNelson Join 🔗
0
10
24
@OFIDJournal
Open Forum Infectious Diseases
8 months
Aztreonam-avibactam demonstrates potent activity against carbapenem-resistant Enterobacterales collected from US medical centers over a six-year period (2017?2022) ✅ Just Accepted 🔗 https://t.co/SdQ1tXcPwR
0
14
36
@OFIDJournal
Open Forum Infectious Diseases
8 months
A Diagnostic Stewardship Success: Implementing a Urine Culture Reflex Policy in the Emergency Department of a Large Safety-Net Hospital ✅ Just Accepted 🔗 https://t.co/Zs76tYsxZ0
0
3
14
@CIDJournal
Clinical Infectious Diseases
8 months
Plasma Microbial Cell-free DNA Metagenomic Sequencing for Diagnosis of Invasive Fungal Diseases Among High-risk Outpatient and Inpatient Immunocompromised Hosts 🔗 https://t.co/QyU77JUwAv
0
6
5
@OFIDJournal
Open Forum Infectious Diseases
9 months
Effectiveness of ampicillin/sulbactam versus ceftriaxone for the initial treatment of community-acquired pneumonia in older adults: a target trial emulation study ✅ Just Accepted ✍️ @bizarreID https://t.co/goqA0XeKc1
Tweet card summary image
academic.oup.com
In older adults with community-acquired pneumonia, ampicillin-sulbactam was associated with a higher mortality rate than ceftriaxone, suggesting that ceftr
2
29
70
@CIDJournal
Clinical Infectious Diseases
9 months
Development and Evaluation of a Novel Algorithm to Identify Doxy-PEP Users at a Large Healthcare System in the Bronx, New York ✅ Just Accepted 🔗 https://t.co/WTWamhhZdq
0
1
6
@IDSAInfo
IDSA
9 months
Spread knowledge, not diseases. 📚 IDSA and @HIVMA staff attend today’s #StandUpForScience rally in Washington DC.
1
15
50
@CIDJournal
Clinical Infectious Diseases
10 months
What's Hot This Year in ID Clinical Science ✅ Just Accepted 🔗 https://t.co/ZIfxPUW7fh
0
10
17
@IDSAInfo
IDSA
10 months
An updated guideline on the treatment of #TB in children and adults is now available! ⬇️ https://t.co/hiM7GUPK8Y Developed by IDSA, @atscommunity, @CDCgov and @EuroRespSoc, the guideline is for settings where diagnostic tools like mycobacterial cultures are routinely available.
0
46
84